Health Economics and Policy Challenges in Global Emerging Markets

Editors: Mihajlo Jakovljevic (Health Economics & Pharmacoeconomics, The Faculty of Medical Sciences University of Kragujevac, Kragujevac, Serbia)



This book is an attempt to tackle some of the key global health challenges with a focus on the leading, emerging countries and mature free-market economies facing similar issues. It consists of seven chapters written by well-recognized scholars in the field affiliated to academia, pharmaceutical industry and hospital sectors based in Japan, USA, China, Germany, Netherlands, Switzerland, Ireland, Serbia, Bulgaria, Poland and Albania. The contributors had diverse expert profiles in health economics, clinical medicine, public health and population aging. Regional health care issues were processed and referred to the BRICS and N-11 nations, North American region, Far East Asia, Western and Eastern Europe. Some of the difficulties of contemporary health systems tackled in certain chapters were: population aging, health spending, insurance coverage, health technology assessment, costs of pharmaceutical development, neurological disorder and diabetes economics, public health legislation and caregiver assessment in a traditional Asian setting. All of the aforementioned research might give a dynamic impetus and expand a mental horizon to the professionals dealing with these issues. We believe that this book deserves a broad global audience consisting of health care professionals, policy makers, health economists, clinical physicians and lay persons eager to expand their knowledge in the field. Our attitude is based on the worldwide academic recognition of the listed contributors. The degree of success of these ambitiously targeted efforts will be assessed by our esteemed audience in years to come.

Table of Contents:

Preface

Chapter 1
BRICS VS. N-11: Population Aging and Health Expenditures in Global Emerging Markets - Historical Records and UN Forecasts 1975 – 2025
(Mihajlo Jakovljevic, Genc Burazeri, Olivera Milovanovic, Nemanja Rancic, Ulrich Laaser, Health Economics & Pharmacoeconomics, The Faculty of Medical Sciences University of Kragujevac, Kragujevac, Serbia, and others)

Chapter 2
What can Emerging Markets Learn from a Public Long-Term Care Insurance System from a Mature Country: Experimental Study?
(Weihong Zeng, ChiaChing Chen, Tetsuji Yamada, Joseph R. Harris, Osama Hamed, Babu N.S. Dasari, I-Ming Chiu, Tadashi Yamada, Xi'an Jiaotong University, China, and others)

Chapter 3
Incorporation of Multi-Criteria Decision Analysis into Health Technology Assessment: Experiences and Challenges from Bulgaria
(Georgi Iskrov, Ralitsa Kuncheva, Rumen Stefanov, Department of Social Medicine and Public Health, Faculty of Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria, and others)

Chapter 4
Willingness-to-Pay for a New Pharmaceutical: Is it Worth the Money? Whose Money?
(Michèle Sennhauser, Peter Zweifel, Zurich, Switzerland, and others)

Chapter 5
The Health Economics of Non-Epileptic Attack Disorder in Ireland
(James A. Magee, and Gillian M. Fortune, Department of Psychology, St John of God Hospital, Dublin, Ireland, and others)

Chapter 6
Legislative Challenges for the Polish Public Health System in the Opinions of Stakeholders
(Romaniuk Piotr, Brukało Katarzyna, Department of Health Policy, Faculty of Public Health Medical University of Silesia, Poland)

Chapter 7
How to Measure Family Caregiver’s Experience with Long-Term Care in Traditional East-Asian Societies: An Example of Adjusting the Caregiver Reaction Assessment Scale using Japanese Data
(Seiritsu Ogura, Bernard Van der Berg, Faculty of Economics, Hosei University, Tokyo, Japan, and others)

Index